Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML - HSA Drug Approval Details

Approvals/HSA/NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML

Approved

THERAPEUTIC

NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML

Biocon Biologics India Limited🇸🇬 Health Sciences Authority

Approval Date: Dec 8, 2021
Approval ID: cc4bb8ec72de61d2
Company: Biocon Biologics India Limited
Type: Therapeutic

Approval Details

Approval Id: cc4bb8ec72de61d2
Drug Name: NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML
Product Name: NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML
Approval Number: SIN16393P
Approval Date: 2021-12-08
Registrant: PHARMA TO MARKET PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SOLUTION
Route Of Administration: SUBCUTANEOUS
Atc Code: L03AA13
Atc Item Name: pegfilgrastim
Pharma Manufacturer Name: PHARMA TO MARKET PTE. LTD.
Company Detail Path: /organization/d21256c35e9bf747/pharma-to-market-pte-ltd

Active Ingredients

Pegfilgrastim

6mg/syringe

Pegfilgrastim

6mg/syringe

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Dec 8, 2021

Approval ID

cc4bb8ec72de61d2

Type

Therapeutic

Back to HSA Approvals